{
    "id": 29968,
    "fullName": "KDM1A positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "KDM1A positive indicates the presence of the KDM1A gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 23028,
        "geneSymbol": "KDM1A",
        "terms": [
            "KDM1A",
            "AOF2",
            "BHC110",
            "CPRF",
            "KDM1",
            "LSD1"
        ]
    },
    "variant": "positive",
    "createDate": "04/29/2019",
    "updateDate": "04/29/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 16829,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Parnate (tranylcypromine) inhibited Kdm1a (Lsd1) activity and proliferation of human induced pluripotent stem cells (hiPSCs) in culture, resulted in decreased teratoma growth in cell line xenograft models (PMID: 26748182).",
            "molecularProfile": {
                "id": 32071,
                "profileName": "KDM1A positive"
            },
            "therapy": {
                "id": 8202,
                "therapyName": "Tranylcypromine",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 14942,
                    "pubMedId": 26748182,
                    "title": "The effects of LSD1 inhibition on self-renewal and differentiation of human induced pluripotent stem cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26748182"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 16827,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Nardil (phenelzine) inhibited Kdm1a (Lsd1) activity and proliferation of human induced pluripotent stem cells (hiPSCs) in culture, resulted in decreased teratoma growth in cell line xenograft models (PMID: 26748182).",
            "molecularProfile": {
                "id": 32071,
                "profileName": "KDM1A positive"
            },
            "therapy": {
                "id": 8201,
                "therapyName": "Phenelzine",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 14942,
                    "pubMedId": 26748182,
                    "title": "The effects of LSD1 inhibition on self-renewal and differentiation of human induced pluripotent stem cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26748182"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 32071,
            "profileName": "KDM1A positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}